Zydus Lifesciences will be in focus on Wednesday after receiving final USFDA approval for its Verapamil Hydrochloride Extended-Release Tablets in 120 mg, 180 mg, and 240 mg strengths. The drug, a generic version of Calan SR, is used to treat high blood pressure. The approval strengthens Zydus’ US portfolio and supports its ongoing expansion in...Read More
HCLTech shares will be watched after the company announced a strategic collaboration with AWS to accelerate digital transformation in the financial services sector. The partnership aims to modernise legacy systems, enhance customer experiences, and deploy AI-driven, industry-compliant solutions across banking, wealth, and insurance, strengthening long-standing ties between both companies.Read More
Indian stock market presents a dual reality. While Sensex and Nifty approach record highs, a significant number of BSE-listed stocks have seen sharp declines. Over 576 stocks are down by at least 30% from their peaks. This divergence is attributed to valuation excesses and concentrated investment flows into select large-cap companies.Read More
Gallard Steel is set for its market debut with a strong grey market premium of 38%, indicating a potential listing price of Rs 205-210. The engineered castings manufacturer saw an overwhelming subscription of 375.54 times for its Rs 37.5 crore SME IPO, driven by significant demand from non-institutional and retail investors.Read More
Investors will know their Sudeep Pharma IPO allotment status on Wednesday. The offering saw strong demand. Grey market activity suggests a listing premium. Shares may list higher than the issue price. Refunds and demat credits are scheduled for November 27. The company is set to list on November 28 on NSE and BSE. A positive...Read More
HDFC Asset Management Company shares are trading ex-bonus today, November 26, following a 1:1 bonus share issue. Investors who held shares by the end of trading on November 25 are eligible for one bonus share for every share owned. The record date for this bonus issuance was November 26, 2025.Read More
Bharti Airtel shares are under scrutiny as promoter ICIL plans to sell a 0.56% stake for approximately $806 million. This follows a similar divestment by Singtel. The deal occurs after Airtel’s strong Q2 results, with robust EBITDA growth and rising ARPU. Analysts remain optimistic, citing potential tariff hikes and operational strength.Read More
Oil prices saw a slight rebound after a dip, as Ukraine signaled progress towards a peace deal with Russia. This potential agreement could lead to the lifting of sanctions on Russian oil, a development that market analysts suggest might drive prices lower. Meanwhile, expectations of a U.S. Federal Reserve interest rate cut are offering some...Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
